Alkermes News
Most Popular Alkermes Story
Amylin gets FDA OK for weekly diabetes drug Bydureon
Say hello to Bydureon, a once-weekly injectable treatment for Type 2 diabetes finally approved by the FDA on Jan. 27. Amylin Pharmaceuticals ($AMLN) developed the drug using controlled release drug Read more >>
Latest Headlines
- January 31, 2012
- November 22, 2011
- November 9, 2011
- September 19, 2011
- August 24, 2011
- March 4, 2011
- November 17, 2010
- October 20, 2010
- September 22, 2010
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
